RT @BioMedCentral: An article published in @BMCMedicine presents results of the successful phase 2 trial of EuCorVac-19, a recombinant prot…
9,408 followers
77,162 followers
An article published in @BMCMedicine presents results of the successful phase 2 trial of EuCorVac-19, a recombinant protein nanoparticle vaccine that was well-tolerated and induced antibodies in a dose-dependent manner to neutralize SARS-CoV-2. https://t.
353 followers
$INO Ino-4800 was referenced in this Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine November 30, 2022 https://t.co/gpQJx2TZo7 https://t.co/NKDWAwPOL3
451 followers
Excited to see encouraging Phase 2 clinical results from EuCorVac-19, a liposome-displayed RBD vaccine for COVID-19. 1/ https://t.co/C6FlhbtH2j